drugset / Trial / NCT02230007

Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly

NCT02230007 ↗

Phase 4 Completed 6 enrolled Centre Hospitalier Universitaire de Nice
RandomizedParallel-groupSupportive care

Summary

The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population of elderly patients, the therapeutic resources to control the passing pain require in their manipulation a certain caution and are not divested of side effects badly tolerated at this age. An alternative in the opioid presents all its interest. The MEOPA is here an alternative of choice in the care of these pains, in particular in case of pre-existent cognitive achievement, of polypathologies or of polymédication. The gas MEOPA administered to the mask could thus be an effective additive in the physiotherapy treatment of the elderly person. The main objective is to Assess the efficacy , in terms of recovery of the hip and knee joint articular amplitude, of 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment.

Timeline

Start
2013-09-18
Primary completion
2015-02-17
Completion
2015-02-24

Drugs

EvaluationDrugModalityDoseRoute
Subject ENTONOX Other / unclassified — Inhaled

Indications

No indication recorded.